Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 5, 2022, Halozyme Therapeutics, Inc. (the "Company") held its Annual Meeting of Stockholders. Of the 137,772,750 shares of the Company's common stock outstanding as of the record date, 127,251,460 shares were represented at the annual meeting.

The stockholders considered three proposals at the meeting, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on March 25, 2022. The number of votes cast for and against and the number of abstentions and broker non-votes with respect to each matter voted upon are set forth below.

Proposal 1: Election of three Class III directors to hold office for a three-year term expiring at the 2025 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified:



Names                        Votes For        Votes Against        Abstain        Broker Non-Votes
Jeffrey W. Henderson        110,983,960         3,917,902          86,787            12,262,811
Connie L. Matsui            104,769,877         9,727,808          490,964           12,262,811
Helen I. Torley             114,703,295          208,526           76,828            12,262,811

Each of the foregoing candidates were elected and each received affirmative votes from more than a majority of the outstanding shares.

Proposal 2: The advisory vote on the compensation of the Company's named executive officers was as follows:

Votes For Votes Against Abstain Broker Non-Votes


 110,559,045         4,295,540          134,064           12,262,811

The foregoing proposal was approved.

Proposal 3: The vote on a proposal to ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022 was as follows:

Votes For Votes Against Abstain Broker Non-Votes


 126,668,977          510,101           72,382                -

The foregoing proposal was approved.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses